Experts Directory

City of Hope offers members of the media access to scientific and medical experts, innovative research and clinical trials, inspirational human stories and much more.
 
We can connect journalists with scientists and clinicians at the forefront of research, treatment and issues related to cancer, diabetes and other life-threatening diseases.

Breast Cancer

  • Veronica Jones, M.D. - Specializing in breast cancer surgery, Jones focuses her research on health disparities in underserved populations, as well as on new technologies in breast cancer care.
  • Laura Kruper, M.D., M.S. - Kruper led a major study which discovered that 7 out of 10 women who get mastectomies to treat breast cancer do not undergo reconstructive surgery. A frequently sought-after medical expert for TV news and talk shows, Kruper is passionate about improving breast cancer awareness and education.
  • Joanne Mortimer, M.D. - Listed numerous times as one of America’s “Top  Doctors” by Castle Connolly, Mortimer is the Baum Family Professor in Women’s Cancers. She takes a special interest in examining how hormones affect normal and tumor cells.
  • Mina S. Sedrak, M.D., M.S. - An assistant professor specializing in breast oncology in the Department of Medical Oncology & Therapeutics Research, Sedrak has identified older adults as one of the most disproportionately vulnerable and least studied cancer patients, and has dedicated his research and career to improving their treatment. He also conducts research on opportunities and challenges related to social media use for clinical trial accrual.

Business Strategy

  • Harlan Levine, M.D. - Levine is president of strategy and business ventures for City of Hope and a member of the Executive Leadership Team and CEO Council. In these roles, he is accountable for strategy, growth, business development, marketing, product innovation and commercialization, payer strategies, the Center for International Medicine, and the management of the medical group practice.

Cancer Biology

  • Linda Malkas, Ph.D. - Malkas, the M.T. & B.A. Ahmadinia Professor in Molecular Oncology, focuses on how to create therapies to thwart cancer at the molecular level. She developed a therapy against neuroblastoma, a children’s cancer, which will soon be tested in a clinical trial.
  • Markus Müschen, M.D., Ph.D. - Müschen, The Norman and Sadie Lee Foundation Professor in Pediatrics, has developed a revolutionary research program that predicts relapse of acute lymphoblastic leukemia (ALL) and a drug-discovery program that will help to prevent or overcome ALL relapse in children.

CAR T Immunotherapy

  • Stephen J. Forman, M.D. - Forman is the Francis & Kathleen McNamara Distinguished Chair in Hematology and Hematopoietic Cell Transplantation, has been at the forefront of this exciting work for over 40 years and has been instrumental in increasing survival rates of patients with blood cancers during that time. He leads City of Hope’s innovative CAR T program.
  • Behnam Badie, M.D. - Badie, the Heritage Provider Network Professor in Gene Therapy, has performed thousands of brain surgeries and leads groundbreaking research into CAR T cell therapy for glioblastoma, publishing a case study in the New England Journal of Medicine.
  • Christine Brown, Ph.D. - As associate director of the T Cell Therapeutics Research Laboratory, Brown, the Heritage Provider Network Professor in Immunotherapy, provides scientific oversight for the preclinical research program, as well as the ongoing clinical trial program focused on the development of CAR-engineered T cells for the treatment of hematological malignancies and solid tumors.
  • Elizabeth Budde, M.D., Ph.D. - Budde is investigating the use of CAR T cells to treat blood cancers and other diseases. She leads CAR T clinical trials. She is fluent in Mandarin.
  • Larry W. Kwak, M.D., Ph.D. - Kwak, the Dr. Michael Friedman Professor in Translational Medicine, has pioneered breakthrough innovations in immunology and cancer vaccines, earning him a spot on TIME magazine’s 2010 100 most influential people in the world. Kwak recently served on the FDA advisory panel for the first approved CAR T cell therapy.
  • Saul Priceman, Ph.D. - As assistant professor in the Department of Hematology & Hematopoietic Cell Transplantation and associate director of translational sciences in the T Cell Therapeutics Research Laboratory, Priceman is a principal investigator and provides scientific oversight on solid tumor immunotherapy programs focused on the development of CAR-engineered T cells and rational combination approaches for prostate cancer, breast cancer brain metastasis, ovarian cancer, pancreatic cancer and other solid tumor types.
  • Tanya Siddiqi, M.D. - Siddiqi specializes in diagnosing and treating blood cancers, particularly leukemia and lymphoma. She is also principal investigator on a number of CAR T cell therapy clinical trials.
  • Xiuli Wang, Ph.D. - Wang is a research professor in the Department of Hematology & Hematopoietic Cell Transplantation at City of Hope. She researches immunotherapy, including vaccines, as well as CAR T cell therapy in multiple myeloma, non-Hodgkin’s lymphoma and acute lymphocytic leukemia.

Diabetes

  • Fouad R. Kandeel, M.D., Ph.D. - Kandeel is the principal investigator on the islet transplantation trial to determine the safety and efficacy of islet cell transplantation as a treatment for patients with type 1 diabetes.
  • Arthur Riggs, Ph.D. - The Samuel Rahbar Chair in Diabetes & Drug Discovery, Riggs pioneered recombinant DNA techniques that led to the development of synthetic human insulin for the treatment of diabetes in humans.
  • Bart O. Roep, Ph.D. - The Chan Soon-Shiong Shapiro Distinguished Chair in Diabetes, Roep has been on a quest for the last 25 years to find a cure for type 1 diabetes and leads The Wanek Project for Type 1 Diabetes at City of Hope.

Gastrointestinal Cancers

  • Joseph Chao, M.D. - Named one of the “Top Doctors” for oncology by Pasadena Magazine in 2011, Chao joined City of Hope in 2007 as a fellow and advanced rapidly to staff physician and assistant clinical professor with expertise on gastrointestinal, stomach, esophageal and colorectal cancers.
  • Yuman Fong, M.D. - A pioneer both in the operating room and in the laboratory, Fong, The Sangiacomo Family Chair in Surgical Oncology, is one of the most innovative surgeons in the world for liver cancer and has developed numerous new surgical techniques and instruments.

Gene Therapy

  • John Zaia, M.D. - Gene therapy pioneer Zaia serves as the director of City of Hope’s Center for Gene Therapy. Zaia, the Aaron D. Miller and Edith Miller Chair in Gene Therapy, is internationally known and respected for his groundbreaking research into potential gene therapy treatments for HIV.

Genomics

  • Stacy Gray, M.D. - Gray serves on the ASCO Cancer Research Committee, holds multiple leadership roles in a National Institutes of Health research consortium and has presented her research both nationally and internationally. She has numerous peer-reviewed publications in such journals as Journal of Clinical Oncology, Journal of the National Cancer Institute, Journal of Oncology Practice and Genetics in Medicine.
  • Thomas P. Slavin, M.D. - Slavin is an accomplished physician specializing in identifying hereditary diseases and syndromes, including genetic components of cancers — particularly gastrointestinal, genitourinary and rare cancers.
  • Jeffrey Weitzel, M.D. - As a leading genetics researcher, Weitzel, the Dr. Norman & Melinda Payson Professor in Medical Oncology, has devoted his career to helping people and populations at increased risk for developing cancer due to family history or personal risk factors.


Health Care Policy

  • Joseph Alvarnas, M.D. - A practicing hematologist, Alvarnas, vice president of government affairs, speaks frequently to government officials and media about the future of chimeric antigen receptor (CAR) T therapies and costs. He is fluent in Spanish.

Hematology

  • Joseph Alvarnas, M.D. - A practicing hematologist, Alvarnas, vice president for government affairs, speaks frequently to government officials and media about the future of chimeric antigen receptor (CAR) T therapies and costs. He is fluent in Spanish.
  • Michael Caligiuri, M.D. - Outgoing president of the American Association of Cancer Research, Caligiuri is the Deana and Steve Campbell Physician- in-Chief Distinguished Chair and is recognized for his work in immunology, specifically the use of human natural killer cells. More than 1,000 cancer patients have been treated in clinical trials developed or co-developed by Caligiuri.
  • Stephen J. Forman, M.D. - Forman is the Francis & Kathleen McNamara Distinguished Chair in Hematology and Hematopoietic Cell Transplantation, has been at the forefront of this exciting work for over 40 years and has been instrumental in increasing survival rates of patients with blood cancers during that time. He leads City of Hope’s innovative CAR T program.
  • Alex Herrera, M.D. - Herrera leads several clinical trials evaluating immune checkpoint inhibitors and other novel agents for the treatment of relapsed or refractory non-Hodgkin’s lymphoma or classical Hodgkin’s lymphoma and in lymphoma patients undergoing hematopoietic stem cell transplantation. He has published over 40 articles in peer-reviewed publications, abstracts and book chapters, and has been invited to present his work nationally and internationally.
  • Maung Myo Htut, M.D. – Htut is determined to find more effective treatments for multiple myeloma, a rare blood cancer which strikes about 30,000 Americans each year. Htut is conducting multiple clinical trials examining immunotherapy options for myeloma.
  • Larry W. Kwak, M.D., Ph.D. - Kwak, the Dr. Michael Friedman Professor in Translational Medicine, has pioneered breakthrough innovations in immunology and cancer vaccines, earning him a spot on TIME magazine’s 2010 100 most influential people in the world. Kwak recently served on the FDA advisory panel for the first approved CAR T cell therapy.

Kidney Cancer 

  • Sumanta Kumar Pal, M.D. - Pal is an internationally recognized leader in the area of genitourinary cancers. He is the co-director of City of Hope's Kidney Cancer Program and is the head of the kidney and bladder cancer disease team at the institution.

Lung Cancer

  • Karen Reckamp, M.D., M.S. - Reckamp, a member of the City of Hope team since 2007, leads clinical trials aimed at finding new and better treatments for lung cancer, especially in the most advanced and difficult-to-treat cases.
  • Ravi Salgia, M.D., Ph.D. - Salgia leads groundbreaking research on lung cancer biology with the goal of finding better treatment options. He heads oncology and is the Arthur & Rosalie Kaplan Endowed Chair in Medical Oncology.

Pediatric Cancer

  • Joseph Rosenthal, M.D. - Renowned for his skills, research and compassion, Rosenthal treats our children and young adults as the Barron Hilton Chair in Pediatrics.
  • Leo David Wang, M.D., Ph.D. - Dr. Wang attends on the pediatric oncology and stem cell transplant services while maintaining an active research laboratory. His research focuses on utilizing novel mass spectrometry-based phosphoproteomic techniques to identify targetable activation pathways in small numbers of rare cells.

Prostate Cancer

  • Tanya Dorff, M.D. - Associate clinical professor in the Department of Medical Oncology & Therapeutics Research, Dorff serves as head of the Genitourinary Cancers Program at City of Hope. She is an internationally recognized leader in prostate cancer and is renowned for her work in other genitourinary tumor types, including kidney, bladder and penile cancer.
  • Sumanta Kumar Pal, M.D. - Pal is an internationally recognized leader in the area of genitourinary cancers. He is the co-director of City of Hope's Kidney Cancer Program and is the head of the kidney and bladder cancer disease team at the institution.

Public Health

  • Rick Kittles, Ph.D. - Kittles achieved renown in the 1990s for his pioneering work tracing the ancestry of African Americans via DNA testing. He now focuses on prostate cancer and improving health equity.
  • Victoria L. Seewaldt, M.D. - At City of Hope, Seewaldt, the Ruth Ziegler Chair in Population Sciences, leads community outreach education efforts to provide breast cancer education, free breast cancer screenings and treatment, mentorship of young minority scholars, and a forum for community partnered trials.

Skin Cancers

  • Morganna Freeman, D. O. - Freeman has specialized training in leading-edge immunotherapy treatments for melanoma and is conducting further research into its potential in other skin cancers. She has published many peer-reviewed papers, is an honored recipient of advocacy and health policy awards, and speaks Spanish.

Supportive Care Medicine

  • William Dale, M.D., Ph.D. - A widely published expert on the care of older adults with cancer and originator of the GeriOnc hashtag, Dale, the Arthur M. Coppola Family Chair in Supportive Care Medicine, co-chaired the panel that developed the 2018 ASCO Guideline for Geriatric Oncology.
  • Matthew Loscalzo, L.C.S.W. – For more than three decades, Loscalzo, the Liliane Elkins Endowed Professor in Supportive Care Programs, has worked tirelessly to change the culture of treatment beyond simply curing disease. He is both pioneer and innovator, seeing to the physical, mental, emotional, spiritual and social needs of patients, their loved ones and their caregivers.

Surgery - Head and Neck

  • Robert S. Kang, M.D., M.P.H. - As an assistant clinical professor in City of Hope's Division of Head and Neck Surgery, Kang brings his surgical expertise in advanced facial reconstructive and microvascular procedures to patients with complex and challenging head and neck cancers.

Surgery - Neurosurgery

  • Behnam Badie, M.D. - Badie has performed thousands of brain surgeries and leads groundbreaking research into CAR T cell therapy for glioblastoma, publishing a case study in the New England Journal of Medicine.
  • Rahul Jandial, M.D., Ph.D. - As a surgeon, Jandial provides complex surgical treatment to cancer patients. As a scientist, his laboratory investigates the biology of cancer. He has authored 10 books and over 100 academic articles on surgery, neuroscience and cancer biology.

Surgery - Surgical Oncology

  • Yuman Fong, M.D. - A pioneer both in the operating room and in the laboratory, Fong, The Sangiacomo Family Chair in Surgical Oncology, is one of the most innovative surgeons in the world for liver cancer and has developed numerous new surgical techniques and instruments.
  • Laura Kruper, M.D., M.S. - Kruper led a major study which discovered that 7 out of 10 women who get mastectomies to treat breast cancer do not undergo reconstructive surgery. A frequently sought-after medical expert for TV news and talk shows, Kruper is passionate about improving breast cancer awareness and education.
  • I. Benjamin Paz, M.D. - At City of Hope since 1990, Paz is renowned for his expertise in breast cancer, gastrointestinal and rectal cancers, and tumors involving the bone and soft tissues.

Urology

  • Tanya Dorff, M.D. - Associate clinical professor in the Department of Medical Oncology & Therapeutics Research, Dorff serves as head of the Genitourinary Cancers Program at City of Hope. She is an internationally recognized leader in prostate cancer and is renowned for her work in other genitourinary tumor types, including kidney, bladder and penile cancer.
  • Diana Londoño, M.D. - Londoño performs open, endoscopic, laparoscopic and robotic-assisted procedures in patients with urologic cancers and disorders. A native of Mexico City, she speaks Spanish fluently.
  • Sumanta Kumar Pal, M.D. - Pal is an internationally recognized leader in the area of genitourinary cancers. He is the co-director of City of Hope's Kidney Cancer Program and is the head of the kidney and bladder cancer disease team at the institution.